The diagnostic role of PTEN and ARID1A in serous effusions.

about

The diagnostic role of PTEN and ARID1A in serous effusions.

Item

http://www.wikidata.org/entity/Q47369086

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

The diagnostic role of PTEN and ARID1A in serous effusions.

@en

The diagnostic role of PTEN and ARID1A in serous effusions.

@nl

type

Item

label

The diagnostic role of PTEN and ARID1A in serous effusions.

@en

The diagnostic role of PTEN and ARID1A in serous effusions.

@nl

prefLabel

The diagnostic role of PTEN and ARID1A in serous effusions.

@en

The diagnostic role of PTEN and ARID1A in serous effusions.

@nl

P1476

The diagnostic role of PTEN and ARID1A in serous effusions

@en

P2093

Arild Holth

http://www.w3.org/2001/XMLSchema#string

Dolors Cuevas

http://www.w3.org/2001/XMLSchema#string

Jeremias Wohlschlaeger

http://www.w3.org/2001/XMLSchema#string

Martin Tötsch

http://www.w3.org/2001/XMLSchema#string

Maurizio Pinamonti

http://www.w3.org/2001/XMLSchema#string

Pio Zeppa

http://www.w3.org/2001/XMLSchema#string

Thomas Hager

http://www.w3.org/2001/XMLSchema#string

P2860

Tenascin-X is a novel diagnostic marker of malignant mesothelioma

Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with Dasatinib

Pathologic scoring of PTEN immunohistochemistry in endometrial carcinoma is highly reproducible

ARID1A alterations are associated with FGFR3-wild type, poor-prognosis, urothelial bladder tumors.

Clinical assessment of PTEN loss in endometrial carcinoma: immunohistochemistry outperforms gene sequencing.

Potential therapeutic targets in ARID1A-mutated cancers

ARID1A gene mutation in ovarian and endometrial cancers (Review).

ATR inhibitors as a synthetic lethal therapy for tumours deficient in ARID1A.

Loss of ARID1A expression leads to sensitivity to ROS-inducing agent elesclomol in gynecologic cancer cells.

Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium.

P2888

s00428-017-2273-1

P304

425-432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00428-017-2273-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

472

http://www.w3.org/2001/XMLSchema#string

P50

Ben Davidson

P577

2017-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29170871

http://www.w3.org/2001/XMLSchema#string